4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-23-000085
Chief Legal Officer gave up 661 shares (to pay taxes)
- Chief Legal Officer acquired 2,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Siegel Jolie Chief Legal Officer | 2023-08-30 | Option exercise | +2,250 | 27,347 | D: show line 1 in the form | ||
| Siegel Jolie Chief Legal Officer | 2023-08-30 | Shares withheld for taxes | −661 | $2.93 | $1,937 | 26,686 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Siegel Jolie Chief Legal Officer | 2023-08-30 | Option exercise · Performance Restricted Stock Units | −2,250 | 16,500 | D: show line 3 in the form |
Loading xslF345X05/wk-form4_1693512739.xml…